Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Precise clinical treatment of triple-negative breast cancer (TNBC) is an obstacle in clinic. Nanotechnology-assisted photothermal therapy (PTT) is a superior treatment modality for TNBC in terms of precision. However, thermoresistance arising from PTT and insufficient drug release from nanocarriers decrease the efficacy of PTT. AT13387 is a novel HSP90 inhibitor that can weaken thermoresistance and undergoing clinic II phase study, showing satisfactory antitumour activity through molecularly targeted therapy (MTT). Whereas, it has poor solubility. Hence hyaluronic acid and stearic acid were connected by hydrazone bonds and disulfide bonds, forming an amphipathic copolymer that could self-assembled into nanomicelles, followed by encapsulating Cypate and AT13387. These nanomicelles exhibited great features, including achieving mutually synergistic PTT/MTT for overcoming thermoresistance and promoting translocation of drugs, increasing the solubility of Cypate and AT13387, showing a pH/redox dual response that contributes to drug release, and having the ability of active targeting. Thus, the nanomicelles developed in this study may be a promising strategy for the precise treatment of TNBC.
Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249.
Sun, W.; Du, Y.; Liang, X. L.; Yu, C. Y.; Fang, J. J.; Lu, W.; Guo, X. Y.; Tian, J.; Jin, Y. H.; Zheng, J. J. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer. Biomaterials 2019, 217, 119264.
Hwang, S. Y.; Park, S.; Kwon, Y. Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol. Ther. 2019, 199, 30–57.
Bianchini, G.; Balko, J. M.; Mayer, I. A.; Sanders, M. E.; Gianni, L. Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 2016, 13, 674–690.
Jusu, S. M.; Obayemi, J. D.; Salifu, A. A.; Nwazojie, C. C.; Uzonwanne, V.; Odusanya, O. S.; Soboyejo, W. O. Drug-encapsulated blend of PLGA-PEG microspheres: In vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer. Sci. Rep. 2020, 10, 14188.
Tian, Y.; Wang, X. F.; Zhao, S.; Liao, X.; Younis, M. R.; Wang, S. J.; Zhang, C. N.; Lu, G. M. JQ1-loaded polydopamine nanoplatform inhibits c-MYC/programmed cell death ligand 1 to enhance photothermal therapy for triple-negative breast cancer. ACS Appl. Mater. Interfaces 2019, 11, 46626–46636.
Qiao, J. N.; Tian, F. C.; Deng, Y. D.; Shang, Y. K.; Chen, S. J.; Chang, E. H.; Yao, J. Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer. Theranostics 2020, 10, 5305–5321.
Yang, J. C.; Chen, Y.; Li, Y. H.; Yin, X. B. Magnetic resonance imaging-guided multi-drug chemotherapy and photothermal synergistic therapy with pH and NIR-stimulation release. ACS Appl. Mater. Interfaces 2017, 9, 22278–22288.
Huang, L. P.; Li, Y. N.; Du, Y. N.; Zhang, Y. Y.; Wang, X. X.; Ding, Y.; Yang, X. L.; Meng, F. L.; Tu, J. S.; Luo, L. et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat. Commun. 2019, 10, 4871.
Li, Y. L.; Deng, Y. B.; Tian, X.; Ke, H. T.; Guo, M.; Zhu, A. J.; Yang, T.; Guo, Z. Q.; Ge, Z. S.; Yang, X. L. et al. Multipronged design of light-triggered nanoparticles to overcome cisplatin resistance for efficient ablation of resistant tumor. ACS Nano 2015, 9, 9626–9637.
Tian, Y.; Guo, R. R.; Wang, Y. J.; Yang, W. L. Coordination-induced assembly of intelligent polysaccharide-based phototherapeutic nanoparticles for cancer treatment. Adv. Healthc. Mater. 2016, 5, 3099–3104.
Yang, H.; Mao, H. J.; Wan, Z. H.; Zhu, A. J.; Guo, M.; Li, Y. L.; Li, X. M.; Wan, J. L.; Yang, X. L.; Shuai, X. T. et al. Micelles assembled with carbocyanine dyes for theranostic near-infrared fluorescent cancer imaging and photothermal therapy. Biomaterials 2013, 34, 9124–9133.
Yang, Y.; Zhu, W. J.; Dong, Z. L.; Chao, Y.; Xu, L.; Chen, M. W.; Liu, Z. 1D coordination polymer nanofibers for low-temperature photothermal therapy. Adv. Mater. 2017, 29, 1703588.
Zhu, X. J.; Feng, W.; Chang, J.; Tan, Y. W.; Li, J. C.; Chen, M.; Sun, Y.; Li, F. Y. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. Nat. Commun. 2016, 7, 10437.
Chang, M. Y.; Hou, Z. Y.; Wang, M.; Yang, C. Z.; Wang, R. F.; Li, F.; Liu, D. L.; Peng, T. L.; Li, C. X.; Lin, J. Single-atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy. Angew. Chem., Int. Ed. 2021, 60, 12971–12979.
An, X. N.; Zhu, A. J.; Luo, H. H.; Ke, H. T.; Chen, H. B.; Zhao, Y. L. Rational design of multi-stimuli-responsive nanoparticles for precise cancer therapy. ACS Nano 2016, 10, 5947–5958.
Chen, L.; Zhou, L. L.; Wang, C. H.; Han, Y.; Lu, Y. L.; Liu, J.; Hu, X. C.; Yao, T. M.; Lin, Y.; Liang, S. J. et al. Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers. Adv. Mater. 2019, 31, 1904997.
Wang, Z. H.; Li, S. W.; Zhang, M.; Ma, Y.; Liu, Y. X.; Gao, W. D.; Zhang, J. Q.; Gu, Y. Q. Laser-triggered small interfering RNA releasing gold nanoshells against heat shock protein for sensitized photothermal therapy. Adv. Sci. 2017, 4, 1600327.
Wen, Z. F.; Liu, F. Y.; Liu, G. X.; Sun, Q. Y.; Zhang, Y. H.; Muhammad, M.; Xu, Y. Q.; Li, H. J.; Sun, S. G. Assembly of multifunction dyes and heat shock protein 90 inhibitor coupled to bovine serum albumin in nanoparticles for multimodal photodynamic/photothermal/chemo-therapy. J. Colloid Interface Sci. 2021, 590, 290–300.
Li, J. H.; Zhu, D. M.; Ma, W. J.; Yang, Y.; Wang, G. G.; Wu, X. L.; Wang, K. L.; Chen, Y. R.; Wang, F. B.; Liu, W. et al. Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma. Nanoscale 2020, 12, 17064–17073.
Yang, R.; Tang, Q. S.; Miao, F. Q.; An, Y. L.; Li, M. F.; Han, Y.; Wang, X. H.; Wang, J.; Liu, P. D.; Chen, R. Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice. Int. J. Nanomedicine 2015, 10, 7345–7358.
Woodhead, A. J.; Angove, H.; Carr, M. G.; Chessari, G.; Congreve, M.; Coyle, J. E.; Cosme, J.; Graham, B.; Day, P. J.; Downham, R. et al. Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design. J. Med. Chem. 2010, 53, 5956–5969.
Spiegelberg, D.; Abramenkovs, A.; Mortensen, A. C. L.; Lundsten, S.; Nestor, M.; Stenerlöw, B. The HSP90 inhibitor onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: An in vitro and in vivo approach. Sci. Rep. 2020, 10, 5923.
Hu, J. J.; Cheng, Y. J.; Zhang, X. Z. Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale 2018, 10, 22657–22672.
Lin, W. J.; Lee, W. C.; Shieh, M. J. Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery. Carbohydr. Polym. 2017, 155, 101–108.
Lee, W. H.; Rho, J. G.; Han, H. S.; Kweon, S.; Nguyen, V. Q.; Park, J. H.; Kim, W. Self-assembled hyaluronic acid nanoparticle suppresses fat accumulation via CD44 in diet-induced obese mice. Carbohydr. Polym. 2020, 237, 116161.
Cui, T. T. ; Yan, Z. Q. ; Qin, H. S. ; Sun, Y. H. ; Ren, J. S. ; Qu, X. G. A sequential target-responsive nanocarrier with enhanced tumor penetration and neighboring effect
Li, Q. L.; Liu, J.; Fan, H. L.; Shi, L.; Deng, Y.; Zhao, L.; Xiang, M. X.; Xu, Y. R.; Jiang, X. L.; Wang, G. B. et al. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment. Biomaterials 2021, 269, 120388.
Wang, S.; Yu, G. C.; Wang, Z. T.; Jacobson, O.; Lin, L. S.; Yang, W. J.; Deng, H. Z.; He, Z. M.; Liu, Y.; Chen, Z. Y. et al. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release. Angew. Chem., Int. Ed. 2019, 58, 14758–14763.
Kim, H. U.; Choi, D. G.; Lee, H.; Shim, M. S.; Bong, K. W. Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release. Lab Chip 2018, 18, 754–764.
Jiang, X. L.; Fan, X. B.; Xu, W.; Zhao, C. G.; Wu, H. L.; Zhang, R.; Wu, G. Q. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug. J. Control. Release 2019, 316, 196–207.
Cheng, K. M.; Ding, Y. P.; Zhao, Y.; Ye, S. F.; Zhao, X.; Zhang, Y. L.; Ji, T. J.; Wu, H. H.; Wang, B.; Anderson, G. J. et al. Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano Lett. 2018, 18, 3250–3258.
Jin, R.; Sun, J.; Zhou, L. F.; Guo, X. L.; Cao, A. N. Dual-responsive click-crosslinked micelles designed for enhanced chemotherapy for solid tumors. Biomater. Sci. 2020, 8, 2507–2513.
Phan, H.; Taresco, V.; Penelle, J.; Couturaud, B. Polymerisation-induced self-assembly (PISA) as a straightforward formulation strategy for stimuli-responsive drug delivery systems and biomaterials: Recent advances. Biomater. Sci. 2021, 9, 38–50.
Lo, Y. L.; Tsai, M. F.; Soorni, Y.; Hsu, C.; Liao, Z. X.; Wang, L. F. Dual stimuli-responsive block copolymers with adjacent redox- and photo-cleavable linkages for smart drug delivery. Biomacromolecules 2020, 21, 3342–3352.
Jie, K. C.; Zhou, Y. J.; Sun, Q.; Li, B.; Zhao, R.; Jiang, D. E.; Guo, W.; Chen, H.; Yang, Z. Z.; Huang, F. H. et al. Mechanochemical synthesis of pillar[5]quinone derived multi-microporous organic polymers for radioactive organic iodide capture and storage. Nat. Commun. 2020, 11, 1086.
Chen, R. F.; Wang, Y.; Ma, Y.; Mal, A.; Gao, X. Y.; Gao, L.; Qiao, L. J.; Li, X. B.; Wu, L. Z.; Wang, C. Rational design of isostructural 2D porphyrin-based covalent organic frameworks for tunable photocatalytic hydrogen evolution. Nat. Commun. 2021, 12, 1354.
Zhao, D. C.; Yang, N. L.; Wei, Y.; Jin, Q.; Wang, Y. L.; He, H. Y.; Yang, Y.; Han, B.; Zhang, S. J.; Wang, D. Sequential drug release via chemical diffusion and physical barriers enabled by hollow multishelled structures. Nat. Commun. 2020, 11, 4450.
Yin, S. P.; Huai, J.; Chen, X.; Yang, Y.; Zhang, X. X.; Gan, Y.; Wang, G. J.; Gu, X. C.; Li, J. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater. 2015, 26, 274–285.
Chi, Y. Y.; Yin, X. L.; Sun, K. X.; Feng, S. S.; Liu, J. H.; Chen, D. Q.; Guo, C. Y.; Wu, Z. M. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. J. Control. Release 2017, 261, 113–125.
Pant, K.; Neuber, C.; Zarschler, K.; Wodtke, J.; Meister, S.; Haag, R.; Pietzsch, J.; Stephan, H. Active targeting of dendritic polyglycerols for diagnostic cancer imaging. Small 2020, 16, 1905013.
Isaacs, J. S. Hsp90 as a “chaperone” of the epigenome: Insights and opportunities for cancer therapy. Adv. Cancer Res. 2016, 129, 107–140.
Roberts, P. J.; Der, C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26, 3291–3310.